Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

IDEAYA Biosciences Q4 EPS $(0.52) Misses $(0.47) Estimate, Sales $3.92M Miss $8.84M Estimate

Author: Benzinga Newsdesk | February 20, 2024 07:02am
IDEAYA Biosciences (NASDAQ:IDYA) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.47) by 10.64 percent. This is a 4 percent decrease over losses of $(0.50) per share from the same period last year. The company reported quarterly sales of $3.92 million which missed the analyst consensus estimate of $8.84 million by 55.62 percent. This is a 2.46 percent decrease over sales of $4.02 million the same period last year.

Posted In: IDYA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist